LAVCA VC
  • News Feed
  • VC Data
  • Directories
  • Features
  • Tech Growth Coalition
  • LAVCA Gender Diversity
  • Engage
    • VC Council
    • VC Members
  • LAVCA
  • Member Login
  • Member Access

LAVCA VC

  • News Feed
  • VC Data
  • Directories
  • Features
  • Tech Growth Coalition
  • LAVCA Gender Diversity
  • Engage
    • VC Council
    • VC Members
  • LAVCA

ACON Investments and Humus Capital Acquire Argentina’s Biosidus

7 June 2018

ACON Investments in partnership with Humus Capital Partners have acquired a majority stake in Biosidus S.A. and Biosidus Farma S.A. (collectively, “Biosidus”), Argentina’s largest manufacturer and distributor of biosimilar pharmaceuticals.

(Press Release)  WASHINGTON and BUENOS AIRES, Argentina, June 7, 2018 /PRNewswire/ — ACON Investments (“ACON”) announced today that affiliates of ACON Latin America Opportunities Fund IV, L.P., in partnership with Humus Capital Partners (“HCP”), a private equity firm based in Argentina, have acquired a majority equity interest in Biosidus S.A. and Biosidus Farma S.A. (collectively, “Biosidus” or the “Company”), Argentina’s largest manufacturer and distributor of biosimilar pharmaceuticals with exports worldwide to more than 25 countries across four continents.

ACON and HCP will continue Biosidus’ international expansion strategy, building on its track record of more than 150 million doses of biosimilar pharmaceuticals produced over the last two decades. Biosidus’ product portfolio comprises some of the most successful biosimilars developed to date with a focus on the treatment of chronic renal failure, cancer, multiple sclerosis, growth hormone deficiency and osteoporosis, among others. The transaction builds on ACON’s experience as one of the longest continuous investors in Latin America, having managed over $1.6 billion in investments throughout the region over the last two decades, as well as HCP’s proven experience, networks and reputation in Argentina.

Santiago García Belmonte, Biosidus’ CEO and current shareholder, said, “I believe that this investment confirms the value our team has built in Biosidus as one of the premier biosimilar pharmaceutical companies in Latin America and the outstanding opportunities presented by biosimilars around the world. We have been searching for the right partners to take our company to the next level and help us capture those opportunities, and I believe that we have found them in ACON and HCP.”

Jose Miguel Knoell, a Managing Partner of ACON, commented, “We are excited to partner with Santiago and his world-class team to further build on Biosidus’ track record of innovation, production and distribution of affordable life-altering treatments to patients in emerging markets.”

“Biosidus emerged as a pioneer within the proud, Nobel Prize-winning legacy of Argentina’s life sciences ecosystem – we believe that this partnership will continue to add to the Company’s success by making Biosidus financially stronger, more innovative, more competitive and allowing it to continue to expand its global footprint,” remarked Ramiro Lauzan, HCP’s Managing Partner.

About ACON
Founded in 1996, ACON is a Washington, DC-based international private equity investment firm that manages private equity funds and special purpose partnerships that make investments in the United States and Latin America. ACON and its principals have managed approximately $5.3 billion of capital. ACON has professionals in Washington, DC, Los Angeles, São Paulo, Mexico City, and Bogotá. For more information, visit www.aconinvestments.com.

About HCP
Founded in 2010, HCP is a middle-market private equity investment firm based in Buenos Aires. HCP invests primarily in family-owned companies across multiple sectors in Argentina, Chile and Uruguay, often as the local partner of choice for leading international investment firms without a dedicated presence in those countries. For more information, visit www.humuscapital.com.

ACON Investments and Humus Capital Acquire Argentina’s Biosidus was last modified: June 13th, 2018 by Editor
ACONBiosidusHumus CapitalPharmaceutical
0
Facebook Twitter Google +

Tech Growth Membership

The 2023 LAVCA Startup Founders Survey is made possible thanks to the support of LAVCA’s Tech Growth Membership, a group of leading tech companies and investors advancing the tech ecosystem in Latin America including AWS, Mercado Libre, Microsoft, Qualcomm Ventures, SVB, Riverwood Capital, Google and Movile.

VC Partner Events

    Tweets

    • Congratulations to all the winners of the 9th annual LAVCA ESG Deal Awards! Learn more about the winners here:… https://t.co/VSLSO2QDkU

      25-May-2023

      Reply Retweet Favorite
    • Join us at 10 am ET for LAVCA's 9th annual ESG Deal Awards! Join here: https://t.co/idTeK2S6lK #investors #LatAm… https://t.co/bbCEAOfjtd

      25-May-2023

      Reply Retweet Favorite
    • Nicolas Szekasy and Francisco Alvarez-Demalde of LAVCA Member firms @KaszekVentures & Riverwood Capital shared thei… https://t.co/GtxubjgCYD

      22-May-2023

      Reply Retweet Favorite
    • The 9th Annual LAVCA ESG Deal Awards will take place next Thursday, 25 May 2023 at 10 am ET on LinkedIn. LAVCA Mem… https://t.co/NpRQSoZgkJ

      18-May-2023

      Reply Retweet Favorite
    • Join us for "Increasing Participation of Women in Private Capital", the next module in the Inside Private Capital e… https://t.co/eQm8BFtlFg

      16-May-2023

      Reply Retweet Favorite

    Submit VC News

    Have private equity or venture capital related news that you would like to share? Submit your press releases and news to [email protected].

    VC Industry News

    • Goldman Sachs Asset Management Leads ~USD60m Round for Brazil’s Digibee

      30 May 2023
    • Carao Ventures and Intoku Health Lead USD5.5m Pre-Series A for Costa Rica’s Huli

      25 May 2023
    • Niya Partners and Tribe Capital Lead USD20m Series A for Mexico’s Kapital

      25 May 2023
    • QED Investors Reaches USD925m in Final Closings Across Two New Funds

      23 May 2023
    • Index Ventures leads USD26m Round for Latin America’s Liquido

      17 May 2023
    • Big Bets, Angel Invest and RTP Global Invest in USD8m Series for Brazil’s DataMilk

      5 May 2023
    • Community Investment Management Provides USD100m Debt Facility to Mexico’s R2

      5 May 2023
    • ALIVE Ventures and Reinventure Capital Lead USD3.5m Seed Round for Colombia’s BeeReaders

      3 May 2023
    • BAI Capital Leads USD10m pre-Series A for Galactic Holdings

      2 May 2023
    • Alaya Capital, FJ Labs, Mr. Pink and Opera Ventures Invest in Argentina’s Teamcubation

      30 April 2023

    About LAVCA

     

    LAVCA is the Association for Private Capital Investment in Latin America, a not-for-profit membership organization dedicated to supporting the growth of private capital in Latin America and the Caribbean through research, education, networking and advocacy.

    LAVCA Office

        New York City:
        589 8th Ave, 18th Floor
        New York, NY 10018

    Explore LAVCA.org

    • About LAVCA
    • Board, Team, & Advisors
    • Media
    • Contact Us
    • Membership Benefits
    • Members Only Access
    • Education and Programs
    • Research
    • Policy
    • LAVCA VC
    • Contact Us

    @2020 - LAVCA. All Rights Reserved.


    Back To Top